By contrast, inhibition of IKKβ or NF-κB signaling can restore insulin signaling in vitro (85, 86) and systemic IKKβ inhibition can alleviate skeletal muscle and systemic insulin resistance all together (73, 74). The gene discussed is NFKB1; the disease is Insulin resistance.